Dale A. Sander, CFO and Chief Corporate Deve. Officer at Humacyte, Inc. (HUMA), bought 20,600 shares at $2.60 ($52K) on 2022-12-16, disclosed to the SEC on 2022-12-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 600 | $0 | 0.0% |
| 2 | $2.60 | 20,000 | $52K | 100.0% |
| Total | $2.52 avg | 20,600 | $52K | 100% |
| Filing → |
| HUMA | SELL | 2024-08-29 | $526K | — | Filing → |
| HUMA | BUY | 2022-05-18 | $9K | — | Filing → |